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Introduction
Hemophilia is a genetic disease that is 
inherited by x-linked recessively. Hemophilia 
is characterized by bleeding abnormalities due 
to lack of factor VIII or factor IX.1–4 When part 
of the body is injured, the hemostatic process 
is immediately initiated to protect the integrity 
of the body and to prevent further bleeding.5,6 
Platelet activation at the site of injury is followed 
by sequential activation of clotting factors and 
fibrin formation.7 Factor VIII and factor IX are 
essential for thrombin generation and fibrin 
spread. Circulating Factor VIII is bound to 
von Willebrand factor (vWF) to protect from 
proteolytic degradation. Both factor VIII and 
factor IX are encoded by genes located in the 
long arm of the X chromosome. When the gene 
sequence F8 or F9 is interrupted, synthesis of 
factor VIII/factor IX is reduced or absent, or a 
less functionally active form is produced.8
Some studies have reported that clinical 
manifestations between hemophilia A 
(HA) and hemophilia B (HB) do not differ, 
however, conflicting results might occur such 
as in bleeding frequency, clinical scores, the 
need for prophylaxis and the need for joint 
replacement.9Hemophilia B tends to have 
milder symptoms than those with hemophilia 
A, especially in young patients.10 An 
epidemiological study in Scotland has shown 
that HB patients have a hospital admission 
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Abstract
Background: The clinical manifestations of hemophilia A (HA) and hemophilia B (HB)are quite similar; 
however, the bleeding characteristics of these two hemophilia types have been reported to be different. 
This study aimed to explore the bleeding patterns among patients with severe HA and severe HB.
Methods: A cross-sectional study was conducted among patients with severe HA and HB registered 
at the West Java Indonesian Hemophilia Society. The inclusion criteria were patients with severe 
hemophilia diagnosed for at least one year. The bleeding patterns included bleeding episodes and 
bleeding types. The Mann-Whitney test was used to compare bleeding episodes and a chi-square test 
for bleeding types.
Results: In total, 158 severe HA patients and 21 severe HB patients were included with a median 
bleeding frequency per patient per year for HA and HB was 24 (range 0–48) and 24 (range 5–48), 
respectively. The bleeding types in HA and HB were ecchymosis (69% vs. 66.7%), hematoma (62.7% vs. 
61.9%), hemarthrosis (99.4% vs. 100%), epistaxis (46.8% vs. 38.1%), gum bleeding (87.3% vs. 95.2%), 
intracranial hemorrhage (15.2% vs. 9.5%), multiple hematomas (36.7% vs. 47.6%), hemarthrosis-
hematoma (61.4% vs. 61.9%), and hemarthrosis-ecchymosis (69% vs. 61.9%). However, there was no 
significant difference in all types of bleeding between HA and HB.
Conclusions: There is no difference in the pattern of hemorrhage between severe HA and severe HB 
in West Java. However, the bleeding phenotypes in hemophilia has considerable implications in the 
therapeutic process. Further research is needed to optimize the treatment regimens.
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rate of 2 to 3 times lower compared to HA.9 
In contrast, another study has described that 
HA has more frequent bleeding frequency 
compared to HB that is 14.4 times compared 
to 8.63 bleeding time per patient per year.11 
The difference in various bleeding phenotypes 
in hemophilia has considerable implications in 
the therapeutic process, thus, further research 
in this area is needed to optimize treatment 
regimens.9
There are around two thousand HA patients 
registered in the Indonesian Hemophilia 
Society Association at the end of 2017, of 
whom this number is only 10% of the estimated 
individuals with hemophilia.12 The purpose of 
this study was to explore the bleeding pattern 
such as bleeding episodes and bleeding types 
among patients with severe HA and severe HB 
in West Java.
Methods
This study was a cross-sectional study using 
comparative analytical methods. A list of 
hemophilia patients with severe HA and HB 
in West Java was taken from the Indonesian 
Hemophilia Society in the period July 2018–
June 2019. The hemophilia patients must 
have been diagnosed for at least one year. The 
data of bleeding episodes when patients had 
experienced in the last year was collected by 
calling the patients via mobile phone or by 
interviewing the patient directly when the 
patient visited the hospital for control. Further 
confirmation was asked to assess the type of 
bleeding experienced such as ecchymosis, 
hematoma, hemarthrosis, epistaxis, gum 
bleeding, and intracranial hemorrhage. 
The interview format from the Indonesian 
Hemophilia Society West Java was used when 
calling or interviewing the patients. The Ethics 
Committee of Universitas Padjadjaran had 
approved study No. 1248 / UN6.KEP/EC/2019. 
The normality test was used to test thedata 
distribution for age, initial age of diagnosis, and 
bleeding episodes. The episodes of bleeding 
were compared using the Mann Whitney 
test; whereas the type of bleeding between 
hemophilia A and B was compared using chi-
square.
Results
In total, there were 338 hemophilia patients 
registered in the West Java Indonesian 
Hemophilia Society, consisted of 252 severe 
hemophilia and 86 mild-moderate hemophilia. 
Of severe hemophilia patients, only 179 were 
willing to participate, consisting of 158 HA 
and 21 HB; while others were excluded due to 
inactive mobile phone, death, or relocation of 
domiciles outside of West Java. 
The normality test (Kolmogorov-Smirnov 
test) showed that the distribution of age and 
age of diagnosis were not normal distributed, 
thus median value was used. Furthermore, 
the data of bleeding episodes among HA and 
HB was also not normal distributed, thus, the 
Mann Whitney test was used as shown in Table 
1. There was no difference in age between HA 
and HB (median 14 vs 14 years old; p 0.959). 
The age of diagnosis in HA was lower than 
that of HB, however, no statistical difference 
between HA and HB (median 1.75 vs 3 years 
old; p 0.204).
 There were no differences in bleeding 
episodes between severe HA and HB (median 
24 vs 24; p 0.066). The types of bleeding were 
presented, and no statistically significant 
differences in distribution and prevalence 
among HA and HB (Table 3).
Discussion
This study is exploring the bleeding pattern 
such as bleeding episodes and bleeding types 
Table 1  Characteristics and Bleeding Episodes of Hemophilia Patients in Dr. Hasan Sadikin 
General Hospital, West Java, Indonesia
Type of Hemophilia Hemophilia A Hemophilia B P-value
Age; years
     Median (min-max) 14 (2–44) 14 (3–50) 0.959
Age of diagnosis; years
     Median (min-max) 1.75(0–22) 3(0–40) 0.204
Bleeding episodesper year
     Median (min-max) 24 (0–48) 24 (5–48) 0.066
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among patients with severe HA and severe 
HB in West Java. The bleeding patterns in 
hemophilia have considerable implications in 
the therapeutic process.9 The median age of 
patients with both severe HA and HB in West 
Java registered in the Indonesian Hemophilia 
Association is 14 years old. These results are 
different when compared with the median age 
in other studies, of whom for HA and HB is 23 
years old and 28 years old, respectively.11 It 
seems that HA is younger and HB; whereas in 
our study the median age of the patients is very 
young. Furthermore, there is no difference in 
bleeding episodes. In a study published earlier, 
within a period of 36 months, hemophilia 
A patients might have 2,800 hemorrhage 
episodes, whereas hemophilia B has 502 
hemorrhage episodes. Beside, severe HA has 
1,491 joint hemorrhages, and in severe HB 
has 332 joint bleeding. This study also shows 
that bleeding episodes in hemophilia A are 
more than hemophilia B, which is 14.4 vs 8.63 
bleeding/patient/year, respectively.11 The 
differences in the results in our study on the 
median age and bleeding episodes might be 
due to the effect of prophylactic administration 
Table 2   Distribution and Prevalence of Bleeding Types among Patients with Severe 
Hemophilia A and Severe Hemophilia B 
Type of Bleeding HA HB Total P-Value
Ecchymosis
     Yes 109 (69) 14 (66.7) 123 (68.7) 0.829
     No 49(31) 7 (33.3) 56 (31.3)
Hematoma
     Yes 99 (62.7) 13 (61.9) 112 (62.6) 0.947
     No 59 (37.3) 8 (38.1) 67 (37.4)
Hemarthrosis
     Yes 157 (99.4) 21 (100) 178 (99.4) 0.715
     No 1 (0.6) - 1 (0.6)
Epistaxis
     Yes 74 (46.8) 8 (38.1) 82 (45.8) 0.450
     No 84 (53.2) 13 (61.9) 97 (54.2)
Gum bleeding
     Yes 138 (87.3) 20(95.2) 158 (88.3) 0.291
     No 20 (12.7) 1 (4.8) 21 (11.7)
Intracranial bleeding
     Yes 24 (15.2) 2 (9.5) 26 (14.5) 0.489
     No 134 (84.8) 19(90.5) 153 (85.5)
Hematoma multiple
     Yes 58 (36.7) 10 (47.6) 68 (38) 0.333
     No 100 (63.3) 11 (52.4) 111 (62)
Hemarthrosis-Hematoma
     Yes 97 (61.4) 13(61.9) 110(61.5) 0.964
     No 61 (38.6) 8(38.1)
Hemarthrosis-Ecchymosis
     Yes 109 (69) 13(61.9) 69(38.5) 0.513
     No 49 (31) 8(38.1) 57(31.8)
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and more equitable replacement factors in 
the developed countries. In addition, factors 
that can affect the number of episodes of 
bleeding in patients including nutritional 
status,13 the severity of coagulation factor 
deficiency, genetic factors, and the formation 
of inhibitors.14 Further research on differences 
in bleeding patterns by considering those 
confounding factors need to be done. The 
limitation of this study is the recall bias that 
may occur in patients or the family members 
interviewed. 
Furthermore, there are no significant 
differences in the clinical manifestations of the 
bleeding episode and bleeding type between 
severe hemophilia A and B patients in West 
Java. A previous study has shown the same 
result.15 However, intracranial hemorrhage as 
a manifestation of the bleeding type which is 
quite severe and the biggest cause of death 
in people with severe hemophilia has a 
percentage of events almost 2-fold greater in 
hemophilia A when compared with hemophilia 
B (15.2% vs 9.5%).16
In conclusion, there is no difference in the 
pattern of hemorrhage between severe HA and 
severe HB in West Java, however, the bleeding 
phenotypes in hemophilia have considerable 
implications in the therapeutic process. 
Further research is needed to optimize 
treatment regimens.
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